VINCRISTINE IN CHILDREN WITH MALIGNANT SOLID TUMORS.
D000293:Adolescent; D000970:Antineoplastic Agents; D002294:Carcinoma, Squamous Cell; D002648:Child; D005354:Fibrosarcoma; D006689:Hodgkin Disease; D006801:Humans; D007223:Infant; D008228:Lymphoma, Non-Hodgkin; D009369:Neoplasms; D009420:Nervous System; D009447:Neuroblastoma; D012516:Osteosarcoma; D011859:Radiography; D012018:Reflex; D012021:Reflex, Abnormal; D012175:Retinoblastoma; D012509:Sarcoma; D012512:Sarcoma, Ewing; D013724:Teratoma; D014116:Toxicology; D014750:Vincristine; D009396:Wilms Tumor
D000970:Antineoplastic Agents; D014750:Vincristine
ADOLESCENCE; ANTINEOPLASTIC AGENTS; CARCINOMA, EPIDERMOID; CHILD; FIBROSARCOMA; HODGKIN'S DISEASE; INFANT; LYMPHOSARCOMA; NEPHROBLASTOMA; NERVOUS SYSTEM; NEUROBLASTOMA; RADIOGRAPHY; REFLEX, ABNORMAL; RETINOBLASTOMA; SARCOMA, EWING'S; SARCOMA, OSTEOGENIC; TERATOID TUMOR; TOXICOLOGIC REPORT; VINCRISTINE